190 related articles for article (PubMed ID: 38151178)
1. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
2. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
[TBL] [Abstract][Full Text] [Related]
3. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
4. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
[TBL] [Abstract][Full Text] [Related]
5. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
8. Characterization of multiple constituents in Kai-Xin-San prescription and rat plasma after oral administration by liquid chromatography with quadrupole time-of-flight tandem mass spectrometry.
Zhang X; Li Q; Lv C; Xu H; Liu X; Sui Z; Bi K
J Sep Sci; 2015 Jun; 38(12):2068-75. PubMed ID: 25845859
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based approach uncovers the pharmacodynamic components and mechanism of Fructus Tribuli for improving endothelial dysfunction in hypertension.
Wang SY; Sun XC; Lv XY; Li JN; Han B; Liu KL; Wang S; Sheng HG; Zhang C; Guo F; Cui YD
J Ethnopharmacol; 2023 Nov; 316():116749. PubMed ID: 37295575
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
11. Exploration the mechanism of Shenling Baizhu San in the treatment of chronic obstructive pulmonary disease based on UPLC-Q-TOF-MS/MS, network pharmacology and in vitro experimental verification.
Gao Z; Wang J; Lu G; Wu Q; Wang S; Wu X; Ou C; Wu Z; Yu H; Wang Y
J Ethnopharmacol; 2024 Apr; 324():117728. PubMed ID: 38216101
[TBL] [Abstract][Full Text] [Related]
12. The active components and potential mechanisms of Wuji Wan in the treatment of ethanol-induced gastric ulcer: An integrated metabolomics, network pharmacology and experimental validation.
Wu T; Zhang H; Jin Y; Zhang M; Zhao Q; Li H; Wang S; Lu Y; Chen S; Du H; Liu T; Guo W; Liu W
J Ethnopharmacol; 2024 May; 326():117901. PubMed ID: 38341112
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
14. Integrating network pharmacology and pharmacological evaluation to explore the protective mechanism of Ershiwuwei Zhenzhu pill in ischemic stroke.
Wang C; Luo Q; Que H; Luo X; Zhang B; Ding Y; Tan R; Gu J; Gong P
J Ethnopharmacol; 2023 Jan; 301():115847. PubMed ID: 36272491
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective mechanism of
Wang N; Jia YM; Zhang B; Xue D; Reeju M; Li Y; Huang SM; Liu XW
Neural Regen Res; 2017 Apr; 12(4):654-659. PubMed ID: 28553348
[No Abstract] [Full Text] [Related]
16. Explore bioactive ingredients and potential mechanism of Houpo Mahuang decoction for chronic bronchitis based on UHPLC-Q exactive orbitrap HRMS, network pharmacology, and experiment verification.
Gao F; Zhang T; Zhang H; Dai Z; Gu Y; Lu M; Zhang Z; Zeng Q; Shang B; Gao S; Wang N; Xu B; Lei H
J Ethnopharmacol; 2023 Mar; 303():115924. PubMed ID: 36414217
[TBL] [Abstract][Full Text] [Related]
17. Mechanism investigation of Shi-Xiao-San in treating blood stasis syndrome based on network pharmacology, molecular docking and in vitro/vivo pharmacological validation.
Wei X; Gao M; Sheng N; Yao W; Bao B; Cheng F; Cao Y; Yan H; Zhang L; Shan M; Chen P
J Ethnopharmacol; 2023 Jan; 301():115746. PubMed ID: 36179951
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology analysis and animal experiment validation of neuroinflammation inhibition by total ginsenoside in treating CSM.
Li ZY; Dai YX; Wu ZM; Li G; Pu PM; Hu CW; Zhou LY; Zhu K; Shu B; Wang YJ; Cui XJ; Yao M
Phytomedicine; 2024 Apr; 126():155073. PubMed ID: 38417244
[TBL] [Abstract][Full Text] [Related]
19. Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4/PI3K/AKT/FOXO1 pathway: a study of network pharmacology and experimental validation.
Xu M; Zhai W; Zhang Y; Pan J; Li J; Huang S
BMC Complement Med Ther; 2023 May; 23(1):156. PubMed ID: 37173696
[TBL] [Abstract][Full Text] [Related]
20. [Active components and mechanism of Jinwugutong Capsules in treatment of osteoporosis: a study based on UPLC-Q-Exactive-MS/MS combined with network pharmacology].
Yang XS; Song XL; Song XL; Yang YY; Liu W; Yang SL; Shi JN; Shen L; Wan KL; Liu XD
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3360-3372. PubMed ID: 37382019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
